You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ductal Adenocarcinoma of the Prostate

Showing 1 - 25 of 8,948
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha

Recruiting
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • +6 more
  • Omaha, Nebraska
    Urology Cancer Center/XCancer
Nov 29, 2022

Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Oligometastatic Disease
  • FOLFIRINOX chemotherapy
  • Baltimore, Maryland
    Johns Hopkins Hospital
Nov 2, 2023

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Boston (other, diagnostic test, combination product)

Not yet recruiting
  • Pancreatic Cancer
  • +4 more
  • Screening Blood Tests
  • +3 more
  • Boston, Massachusetts
  • +1 more
Nov 3, 2023

Pancreatic Ductal Adenocarcinoma, Pain, Acute Trial in San Francisco (Ketamine, Meaning and Purpose therapy)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Pain, Acute
  • San Francisco, California
    University of California, San Francisco
Oct 12, 2023

Minimal Residual Disease Using Multi-omics Approach

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
  • Shanghai, China
    Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Nov 29, 2023

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be

Recruiting
  • Ductal Adenocarcinoma of the Pancreas
  • Whipple over the splenic artery
  • Total pancreatectomy
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 1, 2023

Adenocarcinoma, Pancreatic Ductal Trial in New York (Autogene cevumeran, Atezolizumab, mFOLFIRINOX)

Recruiting
  • Adenocarcinoma, Pancreatic Ductal
  • Autogene cevumeran
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 21, 2023

Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic body radiotherapy (SBRT)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Sep 15, 2023

Pancreatic Ductal Adenocarcinoma Trial in Israel, United States (The risk assessment questionnaire, Blood specimens, tumor

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • The risk assessment questionnaire
  • +2 more
  • Basking Ridge, New Jersey
  • +12 more
Dec 22, 2022

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Bio-specimen Collection: Blood
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

Predict Lymphovascular Invasion in Pancreatic Ductal

Recruiting
  • Predictive Cancer Model
  • Pancreas Cancer
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Aug 10, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • +12 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 30, 2022

    Carcinoma, Pancreatic Ductal Trial in Trondheim (SonoVue, Chemotherapy)

    Completed
    • Carcinoma, Pancreatic Ductal
    • Trondheim, Norway
      Department of Radiology, St Olavs Hospital
    Jan 17, 2023

    Pancreatic Ductal Adenocarcinoma Trial in Toronto (Durvalumab, Oleclumab)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Sep 22, 2023

    Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor Trial in Petaling Jaya (Dendritic cell + Cytokine-induced killer cell

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Advanced Solid Tumor
    • Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy
    • Tegafur Only Product
    • Petaling Jaya, Kuala Lumpur, Malaysia
      Clinical Oncology Department, Ummc
    Jul 12, 2023

    PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

    Not yet recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
    • (no location specified)
    Jul 9, 2023

    PDAC - Pancreatic Ductal Adenocarcinoma Trial in Nijmegen (CT Perfusion)

    Recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • CT Perfusion
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Hospital
    Dec 20, 2022

    3D Bioprinting for Personalized Treatment in Pancreatic Ductal

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
      • Beijing, Beijing, China
      • +1 more
      Jul 12, 2023

      Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Indianapolis (Lonsurf, Gemcitabine, Nab-Paclitaxel)

      Active, not recruiting
      • Pancreatic Cancer
      • Pancreatic Ductal Adenocarcinoma
      • Indianapolis, Indiana
        Indiana University Melvin & Bren Simon Cancer Center
      Nov 29, 2022

      Tumor, Adenocarcinoma Trial in Houston (Pembrolizumab, lenvatinib)

      Recruiting
      • Tumor
      • Adenocarcinoma
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 13, 2022

      Pancreatic Ductal Adenocarcinoma Trial (NP137, Oxaliplatin, Irinotecan)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • (no location specified)
      Sep 23, 2022

      Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Refractory Non-Small Cell Lung Cancer
      • Washington, District of Columbia
        Georgetown Lombardi Comprehensive Cancer Center
      Sep 1, 2023

      Pancreatic Ductal Adenocarcinoma

      Recruiting
      • PDAC - Pancreatic Ductal Adenocarcinoma
      • Pancreatic Cancer
      • Breath test
      • Collection of matched samples of breath, biofluids and pancreatic tissue
      • London, United Kingdom
        Imperial College Healthcare NHS Trust
      Feb 3, 2023